U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C29H41NO4
Molecular Weight 467.6401
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUPRENORPHINE

SMILES

[H][C@@]12OC3=C4C(C[C@H]5N(CC6CC6)CC[C@@]14[C@@]57CC[C@@]2(OC)[C@]([H])(C7)[C@](C)(O)C(C)(C)C)=CC=C3O

InChI

InChIKey=RMRJXGBAOAMLHD-IHFGGWKQSA-N
InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1

HIDE SMILES / InChI

Molecular Formula C29H41NO4
Molecular Weight 467.6401
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:13:47 UTC 2023
Edited
by admin
on Fri Dec 15 15:13:47 UTC 2023
Record UNII
40D3SCR4GZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUPRENORPHINE
EMA EPAR   EP   INN   JAN   MART.   MI   ORANGE BOOK   VANDF   WHO-DD  
INN  
Official Name English
SUBLOCADE
Brand Name English
BUPRENORPHINE [JAN]
Common Name English
BUPRENORPHINE [EMA EPAR]
Common Name English
SUBOXONE
Brand Name English
Buprenorphine [WHO-DD]
Common Name English
BUPRENORPHINE [VANDF]
Common Name English
BUPRENORPHINE [ORANGE BOOK]
Common Name English
BUPRENORPHINE [EP MONOGRAPH]
Common Name English
buprenorphine [INN]
Common Name English
BUPRENORPHIN
Common Name English
BUPRENORPHINE [MI]
Common Name English
BUPRENORPHINE [MART.]
Common Name English
BUTRANS
Brand Name English
PROBUPHINE
Brand Name English
BRIXADI
Brand Name English
BUPRENORPHINE [EP IMPURITY]
Common Name English
ALKS-5461 COMPONENT BUPRENORPHINE
Code English
TEMGESIC
Brand Name English
Classification Tree Code System Code
WHO-VATC QN07BC51
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
NDF-RT N0000175685
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
WHO-ATC N07BC01
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
LIVERTOX NBK548871
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
NDF-RT N0000175689
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
DEA NO. 9064
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
NCI_THESAURUS C1506
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
WHO-ATC N02AE01
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
NCI_THESAURUS C67413
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
FDA ORPHAN DRUG 79093
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
EMA ASSESSMENT REPORTS SUBOXONE (AUTHORIZED: OPIOID-RELATED DISEASES)
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
WHO-ATC N07BC51
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
WHO-VATC QN07BC01
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
WHO-VATC QN02AE01
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
FDA ORPHAN DRUG 541116
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
Code System Code Type Description
PUBCHEM
644073
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
IUPHAR
1670
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
ChEMBL
CHEMBL511142
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
ECHA (EC/EINECS)
257-950-6
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
NCI_THESAURUS
C61656
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
RXCUI
1819
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY RxNorm
MESH
D002047
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
MERCK INDEX
m2771
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY Merck Index
INN
3403
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
WIKIPEDIA
BUPRENORPHINE
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
FDA UNII
40D3SCR4GZ
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
DRUG CENTRAL
434
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
LACTMED
Buprenorphine
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
DAILYMED
40D3SCR4GZ
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
CAS
52485-79-7
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
EVMPD
SUB05985MIG
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
CHEBI
3216
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
EPA CompTox
DTXSID2022705
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
SMS_ID
100000085263
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
DRUG BANK
DB00921
Created by admin on Fri Dec 15 15:13:47 UTC 2023 , Edited by admin on Fri Dec 15 15:13:47 UTC 2023
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
TARGET->PARTIAL AGONIST
PARTIAL AGONIST
BINDING
Ki
TARGET -> AGONIST
BINDER->LIGAND
BINDING
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
DERIVATIVE -> PARENT
TARGET -> INHIBITOR
BINDING
Ki
TARGET -> INHIBITOR
BINDING
Ki
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
METABOLITE ACTIVE -> PARENT
receptor binding and pharmacological activity
METABOLITE ACTIVE -> PARENT
FECAL; URINE
METABOLITE -> PARENT
receptor binding and pharmacological activity
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC